LETROZOLE DEXCEL

Country: Израел

Језик: Енглески

Извор: Ministry of Health

Активни састојак:

LETROZOLE

Доступно од:

DEXCEL LTD, ISRAEL

АТЦ код:

L02BG04

Фармацеутски облик:

FILM COATED TABLETS

Састав:

LETROZOLE 2.5 MG

Пут администрације:

PER OS

Тип рецептора:

Required

Произведен од:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Терапеутска група:

LETROZOLE

Терапеутска област:

LETROZOLE

Терапеутске индикације:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Датум одобрења:

2016-02-29